why invest in healthcare
Healthcare has a well-developed market structure supportive of new company creation. This dynamism, as well as the diversity of companies serving the healthcare market, provides ample opportunities to capitalize on the accelerating pace of innovation and corresponding scientific breakthroughs in the life sciences.
our edge

Why NicHealth

Focus: Target companies that are developing novel solutions that address unmet medical needs or advance an under-served market
Insights: Apply an operator’s framework to evaluate business models, go-to-market strategies, and valuation of prospective portfolio companies
Discipline: Specialize and conduct extensive fundamental research to gain conviction in both our public and private market investments
Alignment: Invest alongside clients and constrain capacity to maintain flexibility to invest in smaller cap, emerging technology
Experience: Financial markets and industry-operator background distinctly qualifies us to assess opportunities and risks
inception date
January 1, 2017
Separately managed account

Investment Philosophy

We believe that dynamic change often creates a disconnect between a company’s future earnings power and its stock’s valuation. Growth catalysts are often not fully understood and expectations tend to be adjusted upwards gradually. We seek to exploit this inefficiency by investing in dynamic companies exhibiting signals of change that will lead to an acceleration in revenue and/or earnings growth in which our research confirms the company’s growth is sustainable and its stock is a timely investment.

Portfolio Construction

Portfolios are actively managed to continually drive to the strongest investment ideas. Position sizes are based on the conviction in the investment thesis of each company relative to other portfolio holdings and risk exposures. Early warnings signs that suggest deterioration in company fundamentals or earnings strength lead to timely sell decisions.

Risk Management

Risk analysis is essential to minimize uncertainties and enhance potential long-term gains for client portfolios. To understand intended and unintended sources of risk, our investment team leverages quantitative tools with experience, judgment and deep knowledge of the holdings within a portfolio on a daily, weekly and monthly basis.

Typical Investment Policies

Number of Positions:  35–50
Geography:  US-listed public equities, ETFs, preferred securities, and convertible bonds
Capitalization:  Greater than $100M
Security:  Max 15%
Hedging:  May hedge healthcare-related ETFs and short individual securities to exploit short-term opportunities, up to 20% of the portfolio market value
Cash:  Transactional, typically <5% (max 20%)

Driver of Expected Return

Bottom up, research-driven stock selection. Industry weights and factor exposures are a residual of the stock-selection process.
In general, the Life Sciences sector experienced a rapid ascent in April/May, partially driven by increased optimism around the development prospects of a novel SARS-CoV-2 vaccine. We have not invested in any of these vaccine developers (discussed in more detail in our COVID-19 FAQs), nor has our focus migrated to include large-cap BioPharma. We continue to seek high quality companies with novel, long-duration assets that aim to change the standard of care.